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Abstract: Craving is typically thought of as a classically conditioned response characterized 
by an elevated mesolimbic dopamine response to drug-related stimuli. Although this definition 
has spurred considerable research, the clinical impact of the research conducted has been less 
robust. The current review takes a more contemporary approach by conceptualizing craving as 
the breakdown of executive function and relative strengthening of the limbic system, occurring 
in the presence of conditioned cues, leading to a maladaptive craving response (ie, an increased 
likelihood of drug consumption). Working from this framework, the present review focuses 
on four issues in drug craving research: pivotal findings and limitations of cue-reactivity and 
neurocognitive tasks; two main processes of craving that include self-control and reward-based 
explanations; integration of neuroeconomic approaches to craving; and the theoretical implica-
tions and future directions of drug craving research.
Keywords: craving, competing decision systems, executive function, loss of control, sub-
stance abuse
Introduction
“Craving” is the breakdown of executive function and relative strengthening of the 
limbic system, occurring in the presence of conditioned cues, leading to a maladap-
tive craving response (ie, an increased likelihood of drug consumption).1–3 The utility 
of this definition springs from its direct focus on the relationship between craving 
responses and problematic drug consumption. From this viewpoint, neurobehav-
ioral markers of craving are less relevant if they do not reliably predict actual drug 
consumption. Craving, although widely studied, has not been consistently successful 
as a treatment target.4,5
Substance-specific differences in craving appear to be less relevant than alternative 
factors such as treatment status,6 mode of cue, and the match between the cue pre-
sented and the characteristics of the cues present in the individual’s drug use settings.7 
Drug-specific differences in craving are inconsistently observed. The disparity between 
findings could be due to other factors, such as participant characteristics (eg, age), 
mode of physiological measurement, and type of self-reported craving assessment.8 
The majority of reviews on drug craving are not commodity-specific but instead target 
factors such as common regions of activation,9 theoretical approaches,10 or treatment 
status.6 Currently, the exploration of substance-specific differences appears to be less 
relevant than other methodological considerations, and this review therefore focuses 
on craving as manifest across many drugs of abuse.





The practical utility of craving has been questioned due to 
inconsistent translation from theory to treatment.9,10 The most 
prevalent model of craving, the cue-reactivity paradigm, has 
proven crucial to better understanding of the neurobiologi-
cal underpinnings of craving. In addition, the cue-reactivity 
paradigm has provided a framework conducive to measur-
ing physiological responses to cues, typically conceptual-
ized as a stimulus-response relationship. The theoretical 
background of the cue-reactivity paradigm, however, has 
several limitations that could be responsible for ineffec-
tive translation to treatment findings.11 The most relevant 
of these limitations is the dearth of research that integrates 
advancements from the findings of neuroscience, cognitive 
psychology, and behavioral economics. The main goal of the 
present review is to communicate a conceptual and method-
ological framework of neuroeconomics as it applies to the 
study of drug craving. The present paper therefore introduces 
how neuroeconomic tools and methods can provide such a 
synthesis and address many existing limitations of craving 
research. Working from this framework, the present review 
focuses on five issues in drug craving research: pivotal find-
ings and limitations of cue-reactivity and neurocognitive 
task paradigms; the two resultant processes of craving that 
include self-control and reward-based explanations; limita-
tions of existing neuroeconomic approaches to craving and 
how emerging neuroeconomic approaches can fill these gaps; 
and lastly, theoretical implications and future directions of 
drug-craving research.
Cue-reactivity and neurocognitive 
task paradigms: findings  
and limitations
Drug craving is typically defined as a classically conditioned 
response characterized by an elevated mesolimbic dopamine 
response to drug-related stimuli.8,12–14 Working from this 
framework, cue-elicited and/or cue-reactivity paradigms 
are predominantly used to evaluate drug craving.6,11 In cue-
elicited craving studies, subjects’ physiological responses 
(eg, blood oxygen levels via functional magnetic resonance 
imaging [fMRI]; electroencephalography event-related 
potentials) and self-reports of craving (commonly referred to 
as subjective craving) are typically assessed before and after 
the presentation of neutral and/or drug stimuli.
Cue-elicited craving studies have provided a valuable 
insight into important relationships between neural correlates 
of drug cues and regional and systems-level neural networks. 
For example, the accumulating literature has identified that 
four of the most commonly cited loci of activation during 
cue-elicited tasks in non-treatment-seeking individuals are 
the dorsal lateral prefrontal cortex (dlPFC; goal seeking), 
amygdala (conditioned drug seeking), anterior cingulate 
cortex (ACC; affective processing), and orbitofrontal cor-
tex (OFC; expectancy).6 More recently, the insula has been 
identified as an additional region commonly activated during 
craving.15,16 Brain activity in these regions has also been 
shown to predict relapse.17
Comparisons of patterns of neural activation during 
neurocognitive and cue-elicited tasks have isolated the brain 
regions associated with craving (eg, amygdala, ACC, dlPFC, 
OFC, and insula). Relatedly, executive functioning deficits in 
areas such as valuing future events (delay discounting), work-
ing memory, cognitive flexibility, risk taking, and attention 
are consistently related to substance abuse and other impulse 
control disorders (eg, obesity, gambling18–20). Analyses of 
the patterns of neural activation during these neurocognitive 
assessments suggest that task performance reflects the rela-
tive activation in two interconnected neurobiological systems: 
the evolutionarily older impulsive system, which is reward-
driven and housed in limbic and prelimbic areas (eg, ACC, 
amygdala), and the more recently evolved executive system, 
which underlies planning and self-control processes and is 
housed in prefrontal regions (eg, dlPFC). Because of the 
similarity in neural regions implicated in executive function 
and craving, executive functioning deficits may be pivotal 
to understanding craving and may indicate an individual’s 
susceptibility to addiction.21,22
The cue-reactivity paradigm has led to a better under-
standing of the neurobiological underpinnings of addiction; 
however, an over-reliance on cue-reactivity has two main 
limitations: an over-reliance on a classical conditioning 
framework and subsequently an overemphasis on physiologi-
cal measurement of craving.
Much research utilizing the cue-reactivity paradigm 
relies heavily on the theoretical underpinnings of classical 
conditioning.8 Such a framework focuses almost exclusively 
on the neurobiological events that occur within close tem-
poral proximity to the craving response while leaving no 
explanation for events that occur outside that small temporal 
window. This framework does not lend itself well to emerg-
ing evidence that executive system activation mediates a self-
control mechanism during craving.21,23 Further, it excludes 
decision-making processes mediated by the executive system 
that occur prior to the temporal window within which crav-
ing is thought to occur. Conversely, classical conditioning 
accounts of craving exclude what occurs between the craving 
response and drug consumption. More specifically, there is 
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no explanation of the role of the goal-directed behavior that 
is likely mediated via operant learning.16 Although it is likely 
that respondent conditioning occurs during autonomic reward 
seeking (ie, drug seeking without barriers to consumption), 
it is equally likely that prefrontal functions such as working 
memory, attention, and reward valuation are being utilized 
to facilitate goal-directed reward seeking (ie, drug seeking 
in the presence of barriers).15,24 A theoretical framework that 
hopes to explain craving within addiction must encapsulate 
both of these reward-based explanations of drug seeking. 
Second, the cue-reactivity paradigm focuses heavily on 
generalized physiological responses (eg, blood oxygenation 
level dependent, skin conductance, heart rate) that are not 
as sensitive to cue manipulations as are many subjective 
assessments of craving.8 Alternative factors during cue 
presentation are also likely to confound measurement of 
automatic physiological responses.25 Examples are cogni-
tive effort related to the upcoming self-control task26 and 
negative affect linked with the substance user being denied 
the drug to consume.27 An emphasis on physiological 
measurement of craving is also particularly conducive to 
measuring the type of stimulus-response relationships typi-
cally seen in classical conditioning. These two limitations 
may limit methodologies used to explore what is happen-
ing before the craving response and during drug seeking 
behavior (ie, after the craving response). This is particu-
larly undesirable as the utility of craving as a construct is 
inexorably linked with its relationship to maladaptive drug 
consumption. Together, the over-reliance on physiological 
measurement and classical conditioning in cue-elicited 
studies constrains conceptual and methodological efforts 
to understand drug craving.
The field of neuroeconomics, an integration of psychol-
ogy, economics, and neuroscience, may help facilitate the 
interaction of cue-elicited craving with a broader array of 
psychological methods. Neuroeconomics stems in part from 
the rejection of human “rationality” in decision-making 
previously purported by traditional economists.28 For the 
sake of this review, neuroeconomics will be defined as a 
combination of neuroscience, psychology, and behavior 
economic methods that explore complex processes underly-
ing automatic and reflective behavior through the study of 
decision-making under risk and uncertainty, intertemporal 
choice (delay discounting), and social decision-making 
(eg, altruism).29 Based on this definition, studies incorporat-
ing subjective craving scales (eg, Likert 1–10) in conjunc-
tion with a cue-elicited paradigm would not be considered a 
neuroeconomic approach. Many neuroeconomic approaches 
to craving, however, incorporate evidence from studies that 
do not incorporate neuroeconomic methods in order to better 
understand the underlying processes of craving.
Self-control and reward  
processes of craving
The interplay between reward-based (ie, impulsive system) 
and self-control-based (ie, executive system) processes has 
emerged from the neuroeconomic literature as an underlying 
explanation of the transition from craving to maladaptive 
drug consumption.1,2,30 These respective processes are likely 
interdependent, and the failure of one depends in large part 
on individual differences.1,21
Impulsive system activation during craving is closely tied 
to activity of the mesolimbic dopamine system. Reward-based 
processes are argued to underlie the progressively increased 
salience of drug-related cues, to the exclusion of non-drug 
cues. This elevated salience of drug-related cues is thought 
to contribute to the increased propensity of cue-induced 
relapse.31,32 Researchers working from this framework, often 
called incentive salience,13,31 posit that other contributors to 
relapse (eg, irrational decision-making) are a function of 
incentive salience processes. The mesolimbic dopamine sys-
tem is largely thought to influence the reinforcing character-
istics of the drug through activity in the limbic regions.12,33 As 
previously mentioned, however, four of the most commonly 
cited regions of activation during cue-elicited tasks are the 
amygdala, OFC, ACC, and dlPFC, two of which (the OFC 
and dlPFC) are subcomponents of the executive system.34,35 
Additionally, interactions between the mesolimbic dopamine 
system and executive system regions are occurring simulta-
neously during a craving response, suggesting a potential 
dynamic process.36 Thus, craving cannot be solely accounted 
for by appeals to the mesolimbic dopamine system.2,37
Particular brain regions activated during neuroeconomic 
tasks might reveal a moderating function between executive 
and impulsive systems.21 The ACC, for example, is related 
to the individual’s ability to inhibit responding during neu-
rocognitive tasks such as the Go-No-Go38 or Stop-Signal 
Reaction Time Task.39 Although it is unclear what accounts 
for differences in brain activation between similar cue-elicited 
methodologies, one potential explanation is the perceived 
availability of the drug (ie, during the experiment or a 
delayed period afterwards)6. In the end, evidence of executive 
system activation concurrent with impulsive system activa-
tion during cue-elicited tasks suggests that multiple factors 
contribute to craving, not just those deriving from the incen-
tive sensitization theory.





An alternative approach is to conceptualize much of the 
neural response that we associate with craving as a top-down 
(executive system) counter to the cue-elicited mesolimbic 
response. The breakdown of control by these sorts of self-
control networks is associated with a “loss of control” and 
the subjective experience of craving,3,23,40 leading to an 
increased likelihood of drug consumption.9,21 These sorts of 
self-control-based explanations of craving are not mutually 
exclusive from reward-based explanations. Instead, self-
control and reward are likely inter-related modules that, when 
broken down, facilitate the transition from initial drug use to 
dependence.23,41 “Loss of control” can be further categorized 
into subcomponents based on the environmental trigger, such 
as stress, emotion, incentive salience, pain, and/or decision-
making.1 Support for the loss of control that takes place 
during drug craving comes in part from cue-elicited work 
using a 2×2 factorial design to explore neural correlates to 
drug and neutral stimuli in addition to using both substance 
abusers and controls.3,23,41 This methodological adjustment 
from only using drug stimuli alongside treatment and control 
groups has revealed that heroin-dependent individuals have 
shown lower levels of baseline activation in the executive 
system compared with controls when exposed to drug ver-
sus neutral stimuli.23,41 In some instances, baseline levels of 
executive system performance were predictive of the level 
of reactivity participants exhibited toward the drug-related 
cue.40 Interestingly, in a review of 19 cue-elicited studies 
across a variety of substances and cue modalities (eg, visual, 
tactile, video, gustatory), ten of ten studies using active drug-
seeking populations found significant relative activation in 
either the OFC or dlPFC, whereas only one of nine studies 
using treatment-seeking individuals found significant activa-
tion in either region.6 This further supports the link between 
deficits in the executive system and the craving observed in 
more seriously addicted individuals.
A consensus model of craving
A comprehensive model of craving must synthesize both 
reward (impulsive system) and self-control (executive 
system) processes at a behavioral and biological level. 
Whether the neural mechanisms that undergird craving 
work as top-down or bottom-up processes, however, remains 
unclear.21 If one process precedes and causally impacts the 
other, the distinction between a top-down and bottom-up pro-
cess is crucial because the directionality of the process will 
guide treatment efforts. Specifically, if top-down processes 
govern craving responses, interventions that target executive 
processes are indicated, whereas if bottom-up processes 
spur craving, tamping down the impulsive system would 
be suggested.21 A comprehensive model of craving must 
address the degree to which individual differences inform 
top-down or bottom-up treatment strategies.42 Ultimately, 
the utility of any craving model will be judged by its impact 
on treatment efficacy.
Craving may reflect the inter-related processes of self-
control and reward.1,21 Thus, multiple patterns of neural 
activity often undergird a single craving response.3,23,30 For 
example, Yang et al23 discovered that patterns of activation in 
an impulsive system network of the ventral tegmental area, 
amygdala, fusiform cortex, and precuneus were inter-related 
with an interconnected prefrontal system (OFC, superior 
frontal cortex, middle frontal cortex), which is implicated 
in the loss of control following a craving response. Interest-
ingly, the authors suggest that the connections within this 
particular prefrontal system may be indicative of a “loss of 
control” as the user ignores distracting stimuli and engages 
in goal-directed behavior toward drug consumption. Simi-
larly, non-human studies have demonstrated the complexity 
of neural patterns that underlie craving by observing that 
reinstatement following extinction is mediated by three sepa-
rate neurotransmitter pathways, including a glutamatergic 
pathway connecting the prefrontal cortex to the nucleus 
accumbens.2,30,43,44
Intervention studies may provide guidance regarding 
the relative role of top-down and bottom-up processes in 
craving. If strengthening of the executive system through 
neurocognitive training decreases craving, top-down 
processes are suggested.9,30 For example, Volkow et al30 
instructed participants to control their cocaine craving 
while observing drug-related cues. Using a within-subject 
design (baseline, pre-, and post-positron emission tomog-
raphy scans), the researchers found that participants in the 
cognitive control condition were able to control inhibition 
based on an increase in activation in the right inferior frontal 
cortex and a decrease in activation in the nucleus accum-
bens. Interestingly, activation in the nucleus accumbens was 
negatively correlated with that in the right inferior frontal 
cortex when participants attempted to cognitively control 
cravings. The right inferior frontal cortex has been strongly 
associated with inhibition,38 and its relationship with the 
nucleus accumbens represents clinical promise for top-down 
cognitive interventions that impact the fronto-accumbal 
circuit.30 Despite the effort to determine the relative roles of 
top-down versus bottom-up processes in craving, it remains 
difficult to posit which system is a more relevant target for 
treating drug craving.
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Integrating neuroeconomic 
approaches to craving
Many approaches to craving continue to rely heavily on 
cue-elicited and/or associative learning-based approaches, 
thus hampering future empirical efforts. The use of novel 
conceptual and methodological approaches used by neu-
roeconomists may help uncover the behavioral and neuro-
biological mechanisms of craving. Barriers include a lack 
of emphasis on within-subject experimental designs, little 
empirical connection between cue-elicited and cognitive task 
paradigms, a disproportionate focus on the disrupted neural 
mechanisms present during addiction rather than pre-existing 
neural dysfunction,1 and little empirical attention devoted to 
goal-directed behavior that occurs between a maladaptive 
craving response and drug consumption.15
Studies of the neural underpinnings of craving generally 
use group designs comparing measures of craving before 
and after drug cue presentation.10 These designs typically 
do not include the within-subject replication that has been 
the basis of inference in behavioral studies.45 Specifically, 
within-subject replication is needed in order to make infer-
ences about the behavior of any specific individual within 
the study, and is a prerequisite to making strong statements 
about individual differences. Although this emphasis on 
between-subject inference may be justified due to the expense 
of conducting extensive within-subject replication, the loss 
of inferential resolution should not be ignored. The power of 
these sorts of within-subject analyses is well demonstrated 
via work on real-time neurofeedback. Neurofeedback makes 
reward contingent on within-subject patterns of brain acti-
vation, demonstrating one-to-one correspondence between 
a given subject’s experience with the independent variable 
(ie, reward for specific patterns of neural activity) and the 
reported dependent variable.46 This intimate contact with 
the independent variable may be highly effective treatment 
for maladaptive craving. For example, Canterberry et al47 
performed three real-time fMRI sessions and found that 
subjective craving scores and activation in the ACC decreased 
with each consecutive session.
Despite the potential importance of doing so, few studies 
have examined cognitive performance and cue-elicited crav-
ing within the same group of subjects. Such data would allow 
researchers to examine the relationships between cognitive 
performance and craving that mediate individual differences. 
Cognitive function and cue-elicited craving researchers 
often reference each other’s work, but the lack of within-
subject comparisons makes unequivocal statements about 
how these patterns of responding relate to other variables 
difficult (eg, characteristics of population, drug, type of 
neural measurement). Volkow et al,30 for example, found that 
when subjects responded to instructions to inhibit craving, 
activation of metabolic activity in the right inferior frontal 
cortex increased, whereas activity decreased in the right OFC 
and right accumbens. One self-proclaimed limitation of the 
study was a failure to demonstrate a relationship between 
neural activation and subjective cravings. The authors posited 
that the lack of a relationship may have been due to the poor 
sensitivity of the craving measure used (ie, a Likert scale 
about subjective craving) and could be remedied by asking 
participants how much they would be willing to pay for the 
drug. This measure was hypothesized to correlate with the 
relationship between the nucleus accumbens and the medial 
OFC. This task would be similar to the hypothetical purchase 
task used in behavioral economic studies.48,49 Interestingly, 
MacKillop et al49 have recently found this measure to be a 
sensitive measure of cue-elicited cigarette craving. Incorpo-
rating behavioral measures into neurobiological studies in this 
example not only provides the potential for improved valid-
ity in place of subjective measurement of craving, but also 
makes a plethora of research available for cross-referencing.50 
Moreover, neuroeconomic analyses of reward characteristics 
may further identify important differences between clinical 
populations (eg, drug users) and non-clinical populations.18 
Another example comes from Verdejo-Garcia et al,51 who 
examined response inhibition (ie, Stroop performance) before 
and after a drug-related cue in drug users and community 
controls. They found that individuals’ compulsivity scores 
on the Obsessive Compulsive Drug Use Scale52 mediated the 
association between craving and Stroop performance. The 
authors concluded that low-compulsivity individuals would 
benefit more from top-down cognitive control interventions 
and high-compulsivity individuals would be better suited 
for stimulus-response interventions such as cue-exposure 
therapy or neurofeedback. The combination of cognitive 
task and cue-elicited paradigms allowed for researchers to 
pit variables against each other in order to better understand 
the mechanism associated with each individual’s craving.
There is little empirical or conceptual focus on the role 
of pre-existing executive system deficits that might predis-
pose individuals to drug craving and subsequently to drug 
consumption. It is clear that drug dependence contributes 
to neurobiological changes in the brain manifest in both 
executive and impulsive system dysfunction.12,22,33 What has 
been largely ignored, however, is whether executive system 
deficits increase the intensity and likelihood of craving prior 
to drug dependence. Executive functioning deficits observed 





in substance abusers are not independent of addiction, and 
likely reflect a relative imbalance between the executive 
and limbic systems reflected in many maladaptive behav-
iors (eg, overeating, gambling, risky sexual behavior).19,53,54 
Longitudinal work evaluating the predictive utility of execu-
tive function measures can help elucidate the role that the 
executive system deficits play in predisposing individuals to 
craving, and subsequently, dependence.1 Longitudinal efforts 
might approach this problem by evaluating how measures of 
executive function (eg, delay discounting) and craving (eg, 
obsessive-compulsive drinking scale) impact future treatment 
gains. Existing research has failed to show consistent rela-
tionships between treatment success and craving, with some 
studies showing predictive utility of craving measures,55–57 
whereas others do not,4,5 and the cause for disparity across 
studies being unknown. However, the literature linking execu-
tive functions such as delay discounting58–60 and response 
inhibition61 to treatment response is more consistent and 
might provide more sensitive measures of the underlying 
factors controlling executive system dysfunction in craving. 
A predictive model incorporating both executive function 
and craving may provide superior resolution, although we are 
unaware of studies longitudinally examining such a model.
Lastly, little empirical attention has been devoted to 
exploring what factors underlie the goal-directed behavior 
that occurs between a craving response and drug consumption. 
This final limitation encompasses many other limitations, 
including those specific to the cue-reactivity paradigm. 
 Classical conditioning explanations of craving, for example, 
seem to encourage a purely autonomic conceptualization of 
reward processing wherein the drug cue elicits an autonomic 
neurobehavioral response leading to drug consumption. Addi-
tionally, neuropsychology tasks often reveal similar regions of 
activation as those observed in experiments on planning and 
goal-directed behavior.42 Drug seeking can occur without the 
presence of barriers (ie, automatic drug seeking);24 however, 
automatic drug seeking is likely mediated by an amygdala-
dorsal-striatal system whereas drug seeking in the face of bar-
riers (goal-directed drug seeking) is mediated by the insula.16 
What is occurring behaviorally during craving-induced “loss 
of control” is increasingly shown to be indicative of abnor-
malities in the insula region.15 The insula in part  functions 
to process interoceptive effects of drug consumption that 
later serve as stimuli signaling the future likelihood of the 
goal-related occurrence. This might be particularly relevant 
when considering that fairly complex behavior must occur 
(controlled by executive system processes) when substance 
abusers experience barriers between a craving response and 
drug consumption. In this context, the insula is thought to 
contain interoceptive information that functions to process 
the predictive value of future rewards and facilitate goal-
directed behavior.15 Such findings further reveal a need to 
explore performance on neuropsychological tasks, such as 
Go No-Go, delay discounting, and the Iowa gambling task, 
which have all been shown to be correlated with insula activa-
tion in substance abusers.16 Further, a two-choice prediction 
procedure with abstinent users by Paulus et al62 predicted 
continued abstinence after 1 year based on relative activa-
tion in the right insula. Evidence for the role of the insula 
supports the pivotal role that the executive system plays in 
drug-seeking behavior and also provides promising avenues 
for future treatment efforts.
Theoretical implications
Theories on drug craving will contribute most to the interdis-
ciplinary literature by accomplishing two goals, ie, synthesiz-
ing and exploring issues related to both the behavioral and 
neurobiological characteristics of drug craving and directly 
informing effective treatment strategies.
One promising approach that integrates neurobiological 
and behavioral research and may yield novel treatment strat-
egies is the Competing Neurobehavioral Decision Systems 
(CNDS) hypothesis.21,22,34,35,63 The CNDS hypothesis argues 
that a dysregulation in the relative balance between the execu-
tive and impulsive systems can predispose individuals to poor 
decision-making.34,64 This poor decision-making has been 
intimately linked with maladaptive responses, such as drug 
abuse,54,65–67 gambling,20,68 overeating/obesity,19 and other poor 
health behavior.18 By contrast, healthier individuals tend to 
show stronger relative activation in the executive system that 
subserves activities such as valuing future events, response 
inhibition, planning, working memory, and attention.69 As 
described above, the executive system appears to underlie a 
chain of neurological events leading to a loss of control.1,9,30,37 
This chain of neurological events seems to be explained in 
part by interoceptive events that function as conditioned 
stimuli, are mediated by insula activation, and subserve 
goal-directed drug consumption.16
The CNDS hypothesis might be well suited to address sev-
eral of the gaps in the neuroeconomic research on drug craving. 
The ability to identify the individual susceptibility of sub-
stance abusers via physiological and neuropsychological 
measurement is one example. Substance-dependent indi-
viduals have shown behavioral and neurobiological deficits 
in all of the executive function components listed in Table 1 
(eg, valuing future events,21,63,64 working memory,70 planning,71 
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behavioral inhibition,72,73 attention,1,74 behavioral flexibility,71 
and emotional regulation21). Craving research has revealed 
several key mediating networks between the executive and 
impulsive systems such as the fronto-accumbal network in the 
context of cocaine-related cues,75 a frontal network including 
the ventral PFC and OFC downregulating the amygdala 
when presented with emotion-eliciting stimuli,76,77 and a 
prefrontal network connection to the ventral tegmental area 
or nucleus accumbens as a mechanism to inhibit mesolimbic 
dopamine neurons.78,79 Neural networks that correlate with 
neuropsychological tasks can be utilized to better assess 
future susceptibility. Volkow et al,30 for example, found that 
decreases in fronto-accumbal metabolic activity were related 
to decreases in self-reported craving. Xue et al16 manipulated 
participant exposure to previous risky experiences using the 
recently developed Modified Cups Task80 and found that 
relative insular activity predicted the level of risky decisions 
participants made. Such findings might not only elucidate 
predictive markers of potential substance abusers but also 
provide an impetus for treatments that target such deficits 
(eg, neurocognitive training81). The study by Xue et al further 
demonstrated a neuroeconomic approach by creating an indi-
vidualized experimental design that allowed for comparison 
within and across subjects.
There is currently a large imbalance between biomark-
ers of impulsive system craving in response to drug cues 
and  neuropsychological tasks that elicit impulsive system 
activation. Table 2 demonstrates that the impulsive system has 
noticeably fewer hypothesized components and correspond-
ing neuropsychological tasks. One potential explanation is 
that efforts to create neuropsychological tasks measuring 
the impulsive system have instead been utilized to measure 
neuroeconomic events across both systems and immediately 
prior to, during, and following a “loss of control”. Response 
inhibition tasks such as Go No-Go and Stop-Signal Reac-
tion tasks2,9,38,82 are commonly used to measure events prior 
to or during a loss of control and often elicit activation from 
both systems. Failure of the executive system to inhibit two-
system network activity derived from the impulsive system 
during a craving response is assumed by some researchers 
to be indicative of an automatic drug-craving response.83 In 
other words, the individual user has little control over his or 
her behavior from the moment of craving until the presumed 
consumption of the drug. However, this position seems to 
contrast with goal-directed behavior that occurs after “loss 
of control” mediated by complex executive functioning pro-
cesses. Goal-directed drug seeking is purported to include 
connectivity among regions such as the dlPFC, insula, and 
ACC.15 The temporal window between the “loss of control” 
and drug consumption might be a relevant treatment target. 
Specifically, can control be regained following what appears 
to be a maladaptive craving response? Future research might 
evaluate whether neurocognitive training or repetitive trans-
cranial magnetic stimulation (rTMS)/transcranial direct cur-
rent stimulation (tDCS) can strengthen self-control behavior 
following “loss of control.” Such empirical findings should 
further encourage treatment efforts targeting two-system 
dysfunction.2,22,30,41
Researchers using rTMS and tDCS have demonstrated 
that when the executive system is strengthened, craving can 
be reduced.30,84–86 This direct manipulation of neural activ-
ity often provides strong causal evidence that executive 
dysfunction likely underlies craving. Further, Boggio et al84 
induced cue-elicited craving in alcohol abusers as measured 
Table 1 executive system components: neuropsychological task and common regions of activation
Executive system component Cognitive task Common regions of activation
valuing future events Delay discounting Dorsolateral PFC, right OFC, right ventrolateral PFC, and lateral 
inferior parietal cortex;† ventral striatum, medial OFC, medial PFC, 
posterior cingulate cortex, left posterior hippocampus*,63,64,94,95
working memory O-span or n-Back Dorsolateral PFC, ventromedial PFC, dorsal cingulate, frontal poles, 
frontal gyrus, posterior cingulate gyrus†,96
Planning Tower of London Dorsolateral PFC, ventromedial PFC, and parietal cortex;† striatum*,97
Behavioral inhibition Stop-Signal Reaction Time  
Task or Go-No-Go
Right inferior frontal cortex, inferior frontal cortex, dorsolateral 
PFC, right frontal gyrus, right medial gyrus, left cingulate, left 
putamen, medial temporal and inferior parietal cortex†,82,98
Attention Continuous Performance Task Dorsolateral PFC from the posterior parietal cortex, occipital lobe, 
lingual gyrus, and fusiform gyrus†,96,99
Behavioral flexibility wisconsin Card-Sorting Task Middle frontal gyrus, dorsolateral and ventromedial PFC†,100,101
emotional regulation iowa Gambling Task Medial and lateral PFC, OFC, dorsolateral PFC, and ventromedial 
PFC;† ACC*,102–104
Notes: †executive system regions; *impulsive system regions. 
Abbreviations: ACC, anterior cingulate cortex; OFC, orbitofrontal cortex; PFC, prefrontal cortex.





by subjective craving scales and then observed how tDCS 
applied to the dlPFC would impact subjective craving. Cue-
induced craving measured after two active tDCS sessions 
revealed reduced subjective craving. Equally important, crav-
ing could not be induced using the same techniques as used at 
the start of the study. Further support for the CNDS approach 
to craving can be found in the fact that rTMS to the ACC also 
reduces craving.17 This ability of researchers to manipulate 
craving levels and corresponding outcomes measures will 
help the evaluation of various theoretical approaches and 
bring researchers closer to more effective treatment options. 
Studies using rTMS or tDCS provide more flexibility to add 
repeated measures, observe immediate changes in craving, 
and are more cost-effective than fMRI technology. Further 
evaluation of the interaction of rTMS and tDCS technolo-
gies within the craving literature are needed. Relatively few 
existing investigations have used either technology to study 
craving and small sample sizes are often used. Researchers 
utilizing rTMS and tDCS technology, however, also often 
incorporate neuropsychological tasks and measures into their 
methodology, which strengthen the generality of their data.
Although it is difficult to target whether drug craving is a 
top-down or bottom-up process, research targeting executive 
system functioning is presently more feasible. Bickel et al,81 
for example, observed that activation in the dlPFC appears to 
undergird both working memory and valuing future events87 
by demonstrating that working memory training success-
fully increased the individual’s ability to value future events 
(ie, decreased delay discounting rates). Moreover, mindful-
ness training, which also engages the executive system, 
has been shown to increase the individual’s ability to value 
future events88 and decreases cue-elicited alcohol craving,89 
suggesting a common mechanism shared by delay discount-
ing processes and craving. Lastly, Goldstein and Volkow33 
held that a dysfunctional connection between the dlPFC and 
nucleus accumbens reflects the interaction of a breakdown in 
inhibition and maladaptive reward processing, respectively. 
Together, these intervention strategies and exploratory studies 
point toward the role of the executive system, and in particular 
the dlPFC, as useful targets for treating drug craving.
Future directions
Future efforts to treat drug craving effectively may need to 
target the interactions between executive, impulsive, and 
mediating systems (eg, the insula and basal ganglia) in order 
to change goal-directed behavior.15 Currently, therapeutic 
approaches to craving tend to take a bottom-up approach 
aimed at decoupling the associative relationships between 
drug cues and craving responses. These Pavlovian cue expo-
sure approaches are often context-bound, such that laboratory 
treatment gains fail to generalize to natural environments.90 
There are more empirically studied interventions targeting 
executive system deficits than impulsive system deficits. 
Interventions targeting the executive system, therefore, may 
be better suited to treat maladaptive drug craving.1–3,23 Future 
research might target intervention strategies that build up 
specific executive functions related to brain regions that are 
activated during craving tasks (eg, dlPFC, OFC, ACC). In 
addition, future studies should embrace operant strategies for 
measuring and treating drug cravings. Researchers can utilize 
hypothetical purchase tasks,48,49,91 for example, to assess rein-
forcer demand for drug craving in order to assess the predic-
tive and motivational value of the drug.30 In some cases, the 
measures of demand derived from these tasks can provide a 
predictive measure of relative changes in activation between 
two regions, in this case a fronto-accumbal network.30 Future 
researchers should evaluate measures of inhibition, reward 
valuation, and planning in relationship to goal-directed 
behavior following “loss of control”. Specifically, methods 
need to be developed that target differences between 
successful drug seeking following a craving response (ie, 
maladaptive craving response) and unsuccessful drug-seeking 
behavior following a craving response. Such research might 
help to better identify the more effortful characteristics of 
drug seeking that can be incorporated into psychosocial 
interventions.15 Lastly, future work on drug craving should 
Table 2 impulsive system components: neuropsychological task and common regions of activation
Impulsive system component Cognitive task Common regions of activation
Reward-drive and trait impulsivity Barratt impulsiveness Scale ventromedial PFC and mesolimbic regions;* OFC†,105,106
Reflection impulsivity Matching Familiar Figures Task, information 
Sampling Task108,109
Unknown at this time
impulsive choice Delay discounting (immediate choice) ventral striatum, medial orbitofrontal cortex, medial PFC, 
posterior cingulate cortex, and left posterior hippocampus*,63,64
Behavioral disinhibition Stop-Signal Reaction Time Task or Go-No-Go ACC;* right prefrontal cortices†,107,110
Notes: †executive system regions; *impulsive system regions. 
Abbreviations: ACC, anterior cingulate cortex; OFC, orbitofrontal cortex; PFC, prefrontal cortex.
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examine treatment outcomes in relation to changes in drug 
craving. Longitudinal studies can contribute by evaluating if 
executive functioning deficits observed during craving pre-
dict response to treatments. Neuroeconomic tasks (eg, delay 
discounting, hypothetical purchase tasks) in conjunction with 
cue-elicited paradigms may help researchers identify indi-
vidual differences,36,42 potentially allowing for more focused 
treatment strategies (ie, top-down or bottom-up). Combining 
cue-elicited and cognitive tasks into one paradigm illustrates 
how a neuroeconomic approach can simultaneously provide 
both treatment and theoretical utility.
Conclusion
Neuroeconomic approaches are poised to address three over-
arching challenges in craving research: craving research must 
explain behavior before, during, and after a craving response; 
craving efforts need to provide a more fine-grained analysis 
of the goal-directed behavior that occurs during drug-seeking; 
and research must accurately reflect the complex inter-related 
and underlying neurobehavioral systems of craving through 
development of novel neuropsychological tasks.
Arguably the most prevalent barrier to craving research 
is the difficulty in relating a craving response to previous or 
future behavior. The conceptualization underlying the cue-
reactivity paradigm has promoted classical conditioning,8 
which in turn infers the presence of a single craving response 
that triggers a series of complex physiological responses lead-
ing to consumption. Although many behavioral and physi-
ological processes are occurring during the craving response, 
the data only summarize a sliver of time within the overall 
time frame of craving. Neuroeconomics can help remedy this 
by producing more ecologically valid measures of craving. 
Volkow et al,30 for example, suggest the use of a hypothetical 
purchase task,48 which more accurately reflects craving for 
the drug. The task uses parametric manipulations as opposed 
to a simple Likert scale (common in cue-reactivity studies) 
and was argued by Volkow et al to reflect the demand for 
the drug mediated by a fronto-accumbal network. Moreover, 
Gass et al92 used a personal digital assistant to assess craving 
in cigarette smokers in response to varenicline, allowing for 
frequent assessments of craving over long periods of time. 
Such a study could be replicated, but with additional mea-
sures using a cue-elicited paradigm (via fMRI). This would 
allow for a more thorough integration of craving events prior, 
during, and following scans. Additionally, personal digital 
assistants could be used to provide substance abusers with 
neurocognitive training that targets key executive functioning 
components such as delay discounting, response inhibition, 
and risk aversion.15,69 There are many new directions that 
neuroeconomic tasks can take that will broaden our under-
standing of the underpinnings of craving across time.
Treatment of craving must only be considered success-
ful if it directly reduces the likelihood of drug consumption. 
More often than not, drug seeking is goal-directed and not 
automatic.8,15 From a practical standpoint, substance abusers 
often encounter challenges in obtaining drugs that take plan-
ning, cognitive resources, and follow-through to overcome. 
One barrier for researchers is access to participants when 
goal-directed behavior occurs. Often, participants are either 
aware they will receive the drug (eg, replacement therapy) or 
are aware they will not. In either case, there is little evidence 
that the behavioral and neurobiological responses measured 
are indicative of goal-directed drug seeking. Researchers have 
reliably evoked and controlled craving responses underlying 
automatic drug seeking;8 however, there is limited experi-
mental evidence to date reflecting the same in goal-directed 
drug seeking. Available research suggests that goal-directed 
drug seeking in conjunction with automatic drug seeking 
mediate a transition from initial drug use to dependence.93 
Empirical efforts must develop novel analog tasks that mir-
ror goal-directed drug seeking in order to better reflect the 
complexity of underlying neural systems of craving. The task 
will be difficult, but may be crucial in connecting the role of 
craving to a reduction in drug consumption.
The success or failure of any approach to craving will in 
part be tied to its ability to reflect the complex inter-related 
systems that underlie craving. The field of neuroeconomics, 
by definition, holds that such systems mediate decision-
making across intertemporal choice, risk and uncertainty, and 
within a social context.29 Neuroeconomic tasks often reflect 
two-system activation of executive functioning components. 
Delay discounting, for example, has been shown to activate 
regions across both executive and impulsive systems.64 
Response inhibition has also been shown to be mediated by 
both systems.69 In the end, the ability of neuropsychological 
tasks to demonstrate the interaction between systems before, 
during, and after craving will allow for the methodological 
flexibility necessary to better understand drug craving.
In conclusion, craving reflects the relative balance 
between executive and impulsive systems mediated by 
competing processes of self-control and reward.1,2,21,37 The 
present review covers: the role of craving in substance 
abuse and current methods; two main processes of craving, 
including self-control and reward-based explanations; 
limitations of various craving approaches and how emerging 
neuroeconomic approaches can fill these gaps; and, lastly, 





the theoretical implications and future directions of drug-
craving research.
It is likely that craving is a top-down process where deficits 
in the executive system facilitate a breakdown of self- control, 
leading to an increased likelihood of consumption.9,23,40 
Research on the role of drug craving in addiction indicates a 
need for further synthesis of neuroeconomic approaches.
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